Hiv-associated Pneumocystis pneumonia

Proceedings of the American Thoracic Society

Volumn 8, Issue 3, 2011, Pages 294-300

  Huang, Laurence ^a,b   Cattamanchi, Adithya ^a   Davis, J Lucian ^a   Den Boon, Saskia ^c   Kovacs, Joseph ^d   Meshnick, Steven ^e   Miller, Robert F ^f,g   Walzer, Peter D ^h   Worodria, William ^c   Masur, Henry ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acquired immune deficiency syndrome; Dihydropteroate synthase; HIV; Pneumocystis; Pneumocystis pneumonia

Indexed keywords

ATOVAQUONE; CLINDAMYCIN PLUS PRIMAQUINE; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE PLUS TRIMETHOPRIM; FOLINIC ACID; PENTAMIDINE; PYRIMETHAMINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRONCHOSCOPY; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GOLD STANDARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG LAVAGE; NONHUMAN; PATHOGENESIS; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA;

ADRENAL CORTEX HORMONES; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; BETA-GLUCANS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CD4 LYMPHOCYTE COUNT; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE, FUNGAL; HIV INFECTIONS; HUMANS; MUTATION; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PNEUMOTHORAX; POLYMERASE CHAIN REACTION; PRIMARY PREVENTION; RADIOGRAPHY, THORACIC; S-ADENOSYLMETHIONINE; SECONDARY PREVENTION; TETRAHYDROFOLATE DEHYDROGENASE; TOMOGRAPHY, X-RAY COMPUTED; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 80051769833     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201009-062WR     Document Type: Conference Paper

References (70)

1. Kovacs J.A., Masur H. Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. JAMA 2009;301:2578-2585.
2. Vargas S.L., Hughes W.T., Santolaya M.E., Ulloa A.V., Ponce C.A., Cabrera C.E., Cumsille F., Gigliotti F. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001;32:855-861. (Pubitemid 32524818)
3. Larsen H.H., von Linstow M.L., Lundgren B., Hogh B., Westh H., Lundgren J.D. Primary Pneumocystis infection in infants hospitalized with acute respiratory tract infection. Emerg Infect Dis 2007;13:66-72. (Pubitemid 46057839)
4. Meuwissen J.H. Infections with Pneumocystis carinii. Natl Cancer Inst Monogr 1976;43:133-136.
5. Pifer L.L., Hughes W.T., Stagno S., Woods D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978;61:35-41. (Pubitemid 8268789)
6. Peglow S.L., Smulian A.G., Linke M.J., Pogue C.L., Nurre S., Crisler J., Phair J., Gold J.W., Armstrong D., Walzer P.D. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis 1990;161:296-306. (Pubitemid 20056662)
7. Huang L., Beard C.B., Creasman J., Levy D., Duchin J.S., Lee S., Pieniazek N., Carter J.L., del Rio C., Rimland D., et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 2000;182:1192-1198.
8. Ripamonti C., Orenstein A., Kutty G., Huang L., Schuhegger R., Sing A., Fantoni G., Atzori C., Vinton C., Huber C., et al. Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates. J Infect Dis 2009;200:1616-1622.
9. Gianella S., Haeberli L., Joos B., Ledergerber B., Wuthrich R.P., Weber R., Kuster H., Hauser P.M., Fehr T., Mueller N.J. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis 2010;12:1-10.
10. Walzer P.D., Perl D.P., Krogstad D.J., Rawson P.G., Schultz M.G. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med 1974;80:83-93.
11. Gottlieb M.S., Schroff R., Schanker H.M., Weisman J.D., Fan P.T., Wolf R.A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425-1431. (Pubitemid 12240076)
12. Masur H., Michelis M.A., Greene J.B., Onorato I., Stouwe R.A., Holzman R.S., Wormser G., Brettman L., Lange M., Murray H.W., et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981;305:1431-1438. (Pubitemid 12240077)
13. WHO/UNAIDS. AIDS epidemic update [accessed September 30, 2010]. Available from: http://dataunaidsorg/pub/Report/2009/JC1700-Epi-Update-2009-enpdf 2009.
14. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 1990.
15. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 1991.
16. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 1992.
17. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 1993.
18. Regional Office for Europe. HIV/AIDS surveillance in Europe 2008. Stockholm, Sweden: Stockholm European Centre for Disease Prevention and Control; 2009.
19. Mocroft A., Sterne J.A., Egger M., May M., Grabar S., Furrer H., Sabin C., Fatkenheuer G., Justice A., Reiss P., et al. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis 2009;48:1138-1151.
20. Huang L., Hecht F.M., Stansell J.D., Montanti R., Hadley W.K., Hopewell P.C. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination: is early bronchoscopy useful? Am J Respir Crit Care Med 1995;151:1866-1871.
21. Fei M.W., Sant C.A., Kim E.J., Swartzman A., Davis J.L., Jarlsberg L.G., Huang L. Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study. Scand J Infect Dis 2009;41:672-678.
22. Fei M.W., Kim E.J., Sant C.A., Jarlsberg L.G., Davis J.L., Swartzman A., Huang L. Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax 2009;64:1070-1076.
23. Radhi S., Alexander T., Ukwu M., Saleh S., Morris A. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect Dis 2008;8:118.
24. Walzer P.D., Evans H.E., Copas A.J., Edwards S.G., Grant A.D., Miller R.F. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 2008;46:625-633. (Pubitemid 351263506)
25. Fisk D.T., Meshnick S., Kazanjian P.H. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 2003;36:70-78. (Pubitemid 36099100)
26. Davis J.L., Huang L. Pneumocystis pneumonia. In: Volberding PA, Sande MA, Lange J, Greene WC, editors. Global HIV/AIDS Medicine, First ed. Philadelphia: Saunders Elsevier, Inc.; 2007. pp. 309-321.
27. Daley C.L., Mugusi F., Chen L.L., Schmidt D.M., Small P.M., Bearer E., Aris E., Mtoni I.M., Cegielski J.P., Lallinger G., et al. Pulmonary complications of HIV infection in Dar es Salaam, Tanzania: role of bronchoscopy and bronchoalveolar lavage. Am J Respir Crit Care Med 1996;154:105-110. (Pubitemid 26255774)
28. Worodria W., Okot-Nwang M., Yoo S.D., Aisu T. Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum AFB smear-negative. Int J Tuberc Lung Dis 2003;7:117-123. (Pubitemid 36172671)
29. Worodria W., Davis J.L., Cattamanchi A., Andama A., den Boon S., Yoo S.D., Hopewell P.C., Huang L. Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients. Eur Respir J 2010;36:446-448.
30. Kyeyune R., Den Boon S., Cattamanchi A., Davis J.L., Worodria W., Yoo S.D., Huang L. Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. J Acquir Immune Defic Syndr 2010;2010;55:446-350.
31. Kovacs J.A., Hiemenz J.W., Macher A.M., Stover D., Murray H.W., Shelhamer J., Lane H.C., Urmacher C., Honig C., Longo D.L., et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663-671. (Pubitemid 14143939)
32. DeLorenzo L.J., Huang C.T., Maguire G.P., Stone D.J. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987;91:323-327. (Pubitemid 17027605)
33. Huang L., Stansell J., Osmond D., Turner J., Shafer K.P., Fulkerson W., Kvale P., Wallace J., Rosen M., Glassroth J., et al. Pulmonary Complications of HIV Infection Study Group. Performance of an algorithm to detect Pneumocystis carinii pneumonia in symptomatic HIV-infected persons. Chest 1999;115:1025-1032. (Pubitemid 29193673)
34. Gruden J.F., Huang L., Turner J., Webb W.R., Merrifield C., Stansell J.D., Gamsu G., Hopewell P.C. High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol 1997;169:967-975. (Pubitemid 27406887)
35. Larsen H.H., Huang L., Kovacs J.A., Crothers K., Silcott V.A., Morris A., Turner J.R., Beard C.B., Masur H., Fischer S.H. A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis 2004;189:1679-1683. (Pubitemid 38648297)
36. de Oliveira A., Unnasch T.R., Crothers K., Eiser S., Zucchi P., Moir J., Beard C.B., Lawrence G.G., Huang L. Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIVinfected patients. Diagn Microbiol Infect Dis 2007;57:169-176. (Pubitemid 46135875)
37. Davis J.L., Welsh D.A., Beard C.B., Jones J.L., Lawrence G.G., Fox M.R., Crothers K., Morris A., Charbonnet D., Swartzman A., et al. Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax 2008;63:329-334. (Pubitemid 351497945)
38. Morris A., Wei K., Afshar K., Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008;197:10-17. (Pubitemid 351263460)
39. Skelly M., Hoffman J., Fabbri M., Holzman R.S., Clarkson A.B. Jr, Merali S. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet 2003;361:1267-1268. (Pubitemid 36428582)
40. Skelly M.J., Holzman R.S., Merali S. S-adenosylmethionine levels in the diagnosis of Pneumocystis carinii pneumonia in patients with HIV infection. Clin Infect Dis 2008;46:467-471. (Pubitemid 351263534)
41. Kutty G., Hernandez-Novoa B., Czapiga M., Kovacs J.A. Pneumocystis encodes a functional S-adenosylmethionine synthetase gene. Eukaryot Cell 2008;7:258-267. (Pubitemid 351959692)
42. Wang P., Huang L., Davis J.L., Swartzman A., Roth B., Stone J., Wu A.H. A hydrophilic-interaction chromatography tandem mass spectrometry method for quantitation of serum s-adenosylmethionine in patients infected with human immunodeficiency virus. Clin Chim Acta 2008;396:86-88.
43. Tasaka S., Hasegawa N., Kobayashi S., Yamada W., Nishimura T., Takeuchi T., Ishizaka A. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 2007;131:1173-1180. (Pubitemid 46608722)
44. Desmet S., Van Wijngaerden E., Maertens J., Verhaegen J., Verbeken E., De Munter P., Meersseman W., Van Meensel B., Van Eldere J., Lagrou K. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 2009;47: 3871-3874.
45. Kaplan J.E., Benson C., Holmes K.H., Brooks J.T., Pau A., Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58:1-207.
46. Fisk M., Sage E.K., Edwards S.G., Cartledge J.D., Miller R.F. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole. Int J STD AIDS 2009;20:652-653.
47. Benfield T., Atzori C., Miller R.F., Helweg-Larsen J. Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review. J Acquir Immune Defic Syndr 2008;48:63-67. (Pubitemid 351600861)
48. Helweg-Larsen J., Benfield T., Atzori C., Miller R.F. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. J Antimicrob Chemother 2009;64:1282-1290.
49. Crothers K., Huang L. Recurrence of Pneumocystis carinii pneumonia in an HIV-infected patient: apparent selective immune reconstitution after initiation of antiretroviral therapy. HIV Med 2003;4:346-349. (Pubitemid 37304376)
50. Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), Mocroft A, Reiss P, Kirk O, Mussini C, Girardi E, Morlat P, Stephan C, De Wit S, Doerholt K, Ghosn J, et al. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clin Infect Dis 2010;51:611-619.
51. Martin J.N., Rose D.A., Hadley W.K., Perdreau-Remington F., Lam P.K., Gerberding J.L. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis 1999;180:1809-1818.
52. Huang L., Crothers K., Atzori C., Benfield T., Miller R., Rabodonirina M., Helweg-Larsen J. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg Infect Dis 2004;10:1721-1728. (Pubitemid 39319361)
53. Kazanjian P., Armstrong W., Hossler P.A., Lee C.H., Huang L., Beard C.B., Carter J., Crane L., Duchin J., Burman W., et al. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J Infect Dis 2001;183:819-822. (Pubitemid 32171759)
54. Khalil I., Ronn A.M., Alifrangis M., Gabar H.A., Satti G.M., Bygbjerg I.C. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Am J Trop Med Hyg 2003;68:586-589. (Pubitemid 38240499)
55. Ma L., Borio L., Masur H., Kovacs J.A. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis 1999;180:1969-1978.
56. Takahashi T., Endo T., Nakamura T., Sakashitat H., Kimurat K., Ohnishit K., Kitamura Y., Iwamoto A. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan. J Med Microbiol 2002;51:510-515. (Pubitemid 34492980)
57. Nahimana A., Rabodonirina M., Bille J., Francioli P., Hauser P.M. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother 2004;48:4301-4305. (Pubitemid 39434890)
58. Robberts F.J., Chalkley L.J., Weyer K., Goussard P., Liebowitz L.D. Dihydropteroate synthase and novel dihydrofolate reductase gene mutations in strains of Pneumocystis jirovecii from South Africa. J Clin Microbiol 2005;43:1443-1444. (Pubitemid 40364982)
59. Costa M.C., Esteves F., Antunes F., Matos O. Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. J Antimicrob Chemother 2006;58:1246-1249. (Pubitemid 44884145)
60. Siripattanapipong S., Leelayoova S., Mungthin M., Worapong J., Tan-Ariya P. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients. Med Mycol 2008;46:389-392. (Pubitemid 351552496)
61. Alvarez-Martinez M.J., Moreno A., Miro J.M., Valls M.E., Rivas P.V., de Lazzari E., Sued O., Benito N., Domingo P., Ribera E., et al. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn Microbiol Infect Dis 2008;62:34-43.
62. Crothers K., Beard C.B., Turner J., Groner G., Fox M., Morris A., Eiser S., Huang L. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005;19:801-805. (Pubitemid 40834750)
63. Kazanjian P.H., Fisk D., Armstrong W., Shulin Q., Liwei H., Ke Z., Meshnick S. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China. J Infect Dis 2004;189:1684-1687. (Pubitemid 38648298)
64. Lane B.R., Ast J.C., Hossler P.A., Mindell D.P., Bartlett M.S., Smith J.W., Meshnick S.R. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis 1997;175:482-485. (Pubitemid 27052264)
65. Beard C.B., Carter J.L., Keely S.P., Huang L., Pieniazek N.J., Moura I.N., Roberts J.M., Hightower A.W., Bens M.S., Freeman A.R., et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000;6:265-272. (Pubitemid 30396382)
66. Demanche C., Guillot J., Berthelemy M., Petitt T., Roux P., Wakefield A.E. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates. Med Mycol 2002;40:315-318. (Pubitemid 34752331)
67. Helweg-Larsen J., Benfield T.L., Eugen-Olsen J., Lundgren J.D., Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999;354:1347-1351. (Pubitemid 29481631)
68. Kazanjian P., Armstrong W., Hossler P.A., Burman W., Richardson J., Lee C.H., Crane L., Katz J., Meshnick S.R. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000;182:551-557. (Pubitemid 30651053)
69. Takahashi T., Hosoya N., Endo T., Nakamura T., Sakashita H., Kimura K., Ohnishi K., Nakamura Y., Iwamoto A. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol 2000;38:3161-3164.
70. Navin T.R., Beard C.B., Huang L., del Rio C., Lee S., Pieniazek N.J., Carter J.L., Le T., Hightower A., Rimland D. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study. Lancet 2001;358:545-549. (Pubitemid 32772730)